Parker R - Search Results

1

Multiple biological markers in germ cell tumor patients treated with platinum-based chemotherapy.

Perera FP, Motzer RJ, Tang D, Reed E, Parker R, Warburton D, O'Neill P, Albertini R, Bigbee WL, Jensen RH, et al. Perera FP, et al. Among authors: parker r. Cancer Res. 1992 Jul 1;52(13):3558-65. Cancer Res. 1992. PMID: 1319825

2

Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.

Motzer RJ, Reed E, Perera F, Tang D, Shamkhani H, Poirier MC, Tsai WY, Parker RJ, Bosl GJ. Motzer RJ, et al. Among authors: parker rj. Cancer. 1994 Jun 1;73(11):2843-52. doi: 10.1002/1097-0142(19940601)73:11<2843::aid-cncr2820731130>3.0.co;2-d. Cancer. 1994. PMID: 7514956

3

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.

Reed E, Parker RJ, Gill I, Bicher A, Dabholkar M, Vionnet JA, Bostick-Bruton F, Tarone R, Muggia FM. Reed E, et al. Among authors: parker rj. Cancer Res. 1993 Aug 15;53(16):3694-9. Cancer Res. 1993. PMID: 8339278 Clinical Trial.

4

Effect of cadmium on human ovarian cancer cells with acquired cisplatin resistance.

Lee KB, Parker RJ, Reed E. Lee KB, et al. Among authors: parker rj. Cancer Lett. 1995 Jan 6;88(1):57-66. doi: 10.1016/0304-3835(94)03626-t. Cancer Lett. 1995. PMID: 7850774

5

Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin.

Parker RJ, Vionnet JA, Bostick-Bruton F, Reed E. Parker RJ, et al. Cancer Res. 1993 Jan 15;53(2):242-7. Cancer Res. 1993. PMID: 8417816

6

Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry.

Parker RJ, Gill I, Tarone R, Vionnet JA, Grunberg S, Muggia FM, Reed E. Parker RJ, et al. Carcinogenesis. 1991 Jul;12(7):1253-8. doi: 10.1093/carcin/12.7.1253. Carcinogenesis. 1991. PMID: 2070490 Clinical Trial.

7

Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell lines.

Dabholkar M, Parker R, Reed E. Dabholkar M, et al. Among authors: parker r. Mutat Res. 1992 Jun;274(1):45-56. doi: 10.1016/0921-8777(92)90042-2. Mutat Res. 1992. PMID: 1375331

8

Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cells.

Parker RJ, Dabholkar MD, Lee KB, Bostick-Bruton F, Reed E. Parker RJ, et al. J Natl Cancer Inst Monogr. 1993;(15):83-8. J Natl Cancer Inst Monogr. 1993. PMID: 7912534

9

Inhibition of DNA repair and sensitization of cisplatin in human ovarian carcinoma cells by interleukin-1 alpha.

Benchekroun MN, Parker R, Reed E, Sinha BK. Benchekroun MN, et al. Among authors: parker r. Biochem Biophys Res Commun. 1993 Aug 31;195(1):294-300. doi: 10.1006/bbrc.1993.2044. Biochem Biophys Res Commun. 1993. PMID: 8363610

10

Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.

Dabholkar M, Bradshaw L, Parker RJ, Gill I, Bostick-Bruton F, Muggia FM, Reed E. Dabholkar M, et al. Among authors: parker rj. Environ Health Perspect. 1992 Nov;98:53-9. doi: 10.1289/ehp.929853. Environ Health Perspect. 1992. PMID: 1486863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,116 results

Search Page

Filters